National Research Co. (NASDAQ:NRC) Shares Purchased by Algert Global LLC

Algert Global LLC lifted its stake in shares of National Research Co. (NASDAQ:NRC - Free Report) by 94.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 82,921 shares of the company's stock after buying an additional 40,182 shares during the period. Algert Global LLC owned approximately 0.35% of National Research worth $1,896,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. Exchange Traded Concepts LLC grew its position in National Research by 5.3% during the 3rd quarter. Exchange Traded Concepts LLC now owns 14,009 shares of the company's stock worth $320,000 after purchasing an additional 704 shares during the period. Russell Investments Group Ltd. raised its position in National Research by 6.3% during the first quarter. Russell Investments Group Ltd. now owns 14,348 shares of the company's stock valued at $568,000 after acquiring an additional 847 shares in the last quarter. Rhumbline Advisers lifted its holdings in National Research by 4.3% in the second quarter. Rhumbline Advisers now owns 21,453 shares of the company's stock valued at $492,000 after acquiring an additional 892 shares during the period. US Bancorp DE grew its stake in shares of National Research by 2.2% during the 3rd quarter. US Bancorp DE now owns 45,932 shares of the company's stock worth $1,050,000 after purchasing an additional 992 shares during the period. Finally, CWM LLC increased its holdings in shares of National Research by 889.7% during the 2nd quarter. CWM LLC now owns 1,158 shares of the company's stock valued at $27,000 after purchasing an additional 1,041 shares in the last quarter. Hedge funds and other institutional investors own 47.26% of the company's stock.

National Research Stock Performance

NRC traded down $0.06 on Thursday, reaching $19.48. The stock had a trading volume of 50,430 shares, compared to its average volume of 86,254. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. National Research Co. has a 12-month low of $17.62 and a 12-month high of $42.18. The business's 50-day moving average price is $19.76 and its two-hundred day moving average price is $22.82. The company has a market cap of $457.31 million, a P/E ratio of 17.24 and a beta of 0.51.

National Research (NASDAQ:NRC - Get Free Report) last announced its earnings results on Friday, October 25th. The company reported $0.24 earnings per share for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The business had revenue of $35.82 million during the quarter.

National Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be given a $0.12 dividend. The ex-dividend date is Friday, December 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.46%. National Research's dividend payout ratio (DPR) is 42.48%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.